DeepCyte
PrivateLast Round
Seed
Apr 9, 2026
Total Funding Raised
$1.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DeepCyte operates in Healthcare & Life Sciences and is based in Wilmington, Delaware. Its latest recorded funding round was a Seed round in April 2026.
DeepCyte is a techbio company that combines single-cell metabolomics with AI models to detect and predict drug toxicity early for the biopharma industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepCyte Comparables
Compare DeepCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axiom Bio | 87% | |
| Ignota Labs | 79% | |
| VeriSIM Life | 74% |
For institutional investors. Book with your work email.
DeepCyte Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 12, 2026
Grew 75% QoQ from 4 to 7 employees.
- Apr 9, 2026
$2M raised in Seed round.
For institutional investors. Book with your work email.
DeepCyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DeepCyte's valuation, stock price, and market status.
Is DeepCyte a public or private company?
DeepCyte is a private company.
What is the current stock price of DeepCyte?
DeepCyte is a private company, so its shares have no public market price. Caplight tracks DeepCyte's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeepCyte worth (valuation)?
Valuation information for DeepCyte is not publicly available.
Can I buy DeepCyte stock?
DeepCyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeepCyte's last funding round?
DeepCyte's most recent funding round was Seed on April 9, 2026.
Who are the main investors in DeepCyte?
Investor information for DeepCyte is not publicly disclosed.
Will DeepCyte IPO soon?
No public IPO plans have been announced for DeepCyte.
How can I track DeepCyte secondary market activity?
Caplight tracks bids, offers, and trades in DeepCyte's shares on secondary markets.